Across the EU, cannabinoid extracts including cannabinol are classified as unauthorised novel foods under Regulation (EU) 2015/2283, and no Union list authorisation exists in any member state. The Swedish food authority's wording covers cannabinoids as a class, so cannabinol has no lawful food route.

Cannabinol is not itself a controlled substance in Sweden. It is named in none of the Swedish narcotics schedules and is not on the list of substances hazardous to health, and the national public health agency's register of substances under investigation does not include it. The Swedish schedules do control a long list of tetrahydrocannabinol isomers and semi-synthetic derivatives, and recent amendments through 2026 have continued adding to that family, but cannabinol is not among them.

That leaves cannabinol in Sweden governed by two mechanisms rather than by any entry of its own. The first is the 2019 Supreme Court holding that a preparation containing THC is narcotics regardless of concentration - which is a rule about the preparation, not about the headline cannabinoid, and so catches a cannabinol extract carrying trace THC exactly as it catches a CBD one. The second is medicines classification: the medicines agency treats orally taken cannabinoid products with pharmacological effect as medicinal products, and a sleep-positioned cannabinol product sits squarely in that assessment.